Quality by Design-Driven Zeta Potential Optimisation Study of Liposomes with Charge Imparting Membrane Additives

Liposomal formulations, as versatile nanocarrier systems suitable for targeted delivery, have a highly focused role in the therapy development of unmet clinical needs and diagnostic imaging techniques. Formulating nanomedicine with suitable zeta potential is an essential but challenging task. Formul...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Németh Zsófia
Pannonhalminé Csóka Ildikó
Semnani Jazani Reza
Sipos Bence
Haspel Henrik
Kozma Gábor
Kónya Zoltán
Dobó Dorina Gabriella
Dokumentumtípus: Cikk
Megjelent: 2022
Sorozat:PHARMACEUTICS 14 No. 9
Tárgyszavak:
doi:10.3390/pharmaceutics14091798

mtmt:33070907
Online Access:http://publicatio.bibl.u-szeged.hu/25002
LEADER 02727nab a2200301 i 4500
001 publ25002
005 20220902141247.0
008 220902s2022 hu o 0|| Angol d
022 |a 1999-4923 
024 7 |a 10.3390/pharmaceutics14091798  |2 doi 
024 7 |a 33070907  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a Angol 
100 1 |a Németh Zsófia 
245 1 0 |a Quality by Design-Driven Zeta Potential Optimisation Study of Liposomes with Charge Imparting Membrane Additives  |h [elektronikus dokumentum] /  |c  Németh Zsófia 
260 |c 2022 
300 |a Terjedelem: 25 p.-Azonosító: 1798 
490 0 |a PHARMACEUTICS  |v 14 No. 9 
520 3 |a Liposomal formulations, as versatile nanocarrier systems suitable for targeted delivery, have a highly focused role in the therapy development of unmet clinical needs and diagnostic imaging techniques. Formulating nanomedicine with suitable zeta potential is an essential but challenging task. Formulations with a minimum ±30 mV zeta potential are considered stable. The charge of the phospholipid bilayer can be adjusted with membrane additives. The present Quality by Design-derived study aimed to optimise liposomal formulations prepared via the thin-film hydration technique by applying stearylamine (SA) or dicetyl phosphate (DCP) as charge imparting agents. This 32 fractional factorial design-based study determined phosphatidylcholine, cholesterol, and SA/DCP molar ratios for liposomes with characteristics meeting the formulation requirements. The polynomials describing the effects on the zeta potential were calculated. The optimal molar ratios of the lipids were given as 12.0:5.0:5.0 for the SA-PBS pH 5.6 (optimised sample containing stearylamine) and 8.5:4.5:6.5 for the DCP-PBS pH 5.6 (optimised sample containing dicetyl phosphate) particles hydrated with phosphate-buffered saline pH 5.6. The SA-PBS pH 5.6 liposomes had a vesicle size of 108 ± 15 nm, 0.20 ± 0.04 polydispersity index, and +30.1 ± 1.2 mV zeta potential, while these values were given as 88 ± 14 nm, 0.21 ± 0.02, and −36.7 ± 3.3 mV for the DCP-PBS pH 5.6 vesicles. The prepared liposomes acquired the requirements of the zeta potential for stable formulations. 
650 4 |a Farmakológia és gyógyszerészet 
700 0 2 |a Pannonhalminé Csóka Ildikó  |e aut 
700 0 2 |a Semnani Jazani Reza  |e aut 
700 0 2 |a Sipos Bence  |e aut 
700 0 2 |a Haspel Henrik  |e aut 
700 0 2 |a Kozma Gábor  |e aut 
700 0 2 |a Kónya Zoltán  |e aut 
700 0 2 |a Dobó Dorina Gabriella  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/25002/1/2022_Nemeth_QualitybyDesign-drivenzetapotentialoptimisationstudyofliposomeswithchargeimpartingmembraneadditives.pdf  |z Dokumentum-elérés